Treating Upper Airway Inflammation
The SC Therapeutic Pipeline of alkaline HDS aerosols are emitted from soft-mist or dry-powder inhalers to reduce the compression of airway epithelial cells for the treatment of inflammatory conditions of the upper respiratory and cardiovascular systems.
Alkaline HDS Aerosol Therapeutics
Discovery
Preclinical
Phase 2 Ready
Phase 2
Platform 1|SC0032Inhaled alkaline salt ions (pH 9) — Lung diseases associated with cough
SC0032
Refractory Chronic Cough (RCC)
Oral sprayMHRA approved
SC0032
IPF-associated cough
Oral sprayODD available
Platform 2|SC0046Hypertonic Divalent Salt (HDS) — non-cough indication (undisclosed)
SC0046
Undisclosed cardiovascular indication
Non-coughUndisclosed